National Vision Holdings, Inc. (EYE) Stock

National Vision Holdings, Inc. (EYE) is a Healthcare stock trading at $16.80 (as of 2026-09-02), with a market capitalization of $1.35B and a trailing P/E of 28.9. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

National Vision Holdings, Inc., through its subsidiaries, operates as an optical retailer in the United States through two segments: Owned & Host and Legacy. It sells eyeglasses, contact lenses, and optical accessories and provides eye exams through branded store formats and e-commerce channels, serving customers through company-operated retail locations and websites.

Understand National Vision Holdings, Inc.: how it makes money

National Vision runs a U.S. optical retail network (America's Best, Eyeglass World, Vista, Military, Fred Meyer) selling eyeglasses, contact lenses, and eye exams to consumers and managed-care plans. The model depends on foot traffic volume, with managed-care contracts anchoring a share of patient flow and cash-pay consumers providing the higher-margin, more cyclical remainder.

The eye exam drives the customer in; the frame and lens sale is where the real margin is, and managed-care contracts keep the patient pipeline steady while premium-lens attachment stretches the per-patient ticket.

Business quality (Mixed): Steady 7% revenue growth on a volume-driven retail base with an 8.3% operating margin. The 25.4x multiple sits 22% below the Medical Equipment peer average, suggesting the market is pricing in execution risk around the rebrand and consultative-selling programs.

Valuation: At 25× earnings, EYE trades 22% below the Medical Equipment average (33×).

Bull case

  • Managed care anchors patient volume: Management flagged that managed care remains a sizable and growing revenue channel. That gives the store base a contractual, recurring source of patients that is less exposed to consumer spending swings.
  • Premium mix lifts average ticket: Sort changes in premium frame and lens assortments are raising the average ticket per patient. Higher attachment on premium lenses directly expands gross profit per visit without needing new traffic.
  • Trades at a 22% discount: The stock screens at 25.4x earnings versus a 33x Medical Equipment industry average, a 22% gap. If the cost-out plan delivers the margin expansion management outlined, the multiple could re-rate toward peers.

Bear case

  • Cash-pay traffic is softening: Overall customer traffic declined in Q4, led by weaker cash-pay visits, and management noted those consumers remain more sensitive to macro conditions. If the cash-pay share of the mix stays under pressure, same-store growth stalls even as managed care grows.
  • 14,000-person rollout is a bet: The consultative-selling program requires sustained execution across roughly 14,000 employees. Retail training programs of this scale commonly under-deliver in the first 12 to 18 months, and any slip would delay the margin upside the bull case depends on.
Valuation — source: SEC EDGAR (first-party)
Price$16.80
Market Cap$1.35B
P/E Ratio28.9
EV / EBITDA8.9
Price / Book1.50
Price / Sales0.67
FCF Yield5.5%
DCF Value (model)$0.48
DCF Upside vs Price-97.1%
Profitability & Growth — source: SEC EDGAR
Revenue (TTM)$1.99B
Net Margin1.5%
Revenue Growth (YoY)33.3%
EPS Growth (YoY)-111.5%
FCF Growth (YoY)546.7%
Financial Health — source: SEC EDGAR
Altman Z-Score1.89 (grey)
Valuation vs Sector & Industry
Stock P/E28.9
Sector P/E (Healthcare)21.6
Industry P/E (Medical Equipment)29.8
vs Sector33.8%
vs Industry-2.9%
Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Insider Sells (12mo)2
Top Institutional HolderBlackRock, Inc. ($298.77M)
Institutional Holders Tracked10
Company
SectorHealthcare
IndustryMedical Equipment
CEOAlexander N. Wilkes
Employees13,411
CountryUS
IPO Date2017-10-27

National Vision Holdings, Inc. earnings call transcripts

  • EYE Q4 FY25 earnings call transcript (reported 2026-03-04) · analysis

All EYE earnings calls

Related Companies (Medical Equipment; 8 comparable device makers)

  • The Cooper Companies, Inc. (COO)
  • Teleflex Incorporated (TFX)
  • Integer Holdings Corporation (ITGR)
  • ICU Medical, Inc. (ICUI)
  • STAAR Surgical Company (STAA)
  • Enovis Corporation (ENOV)
  • Integra LifeSciences Holdings Corporation (IART)
  • Bio-Rad Laboratories, Inc. (BIO)
EYE earnings history · EYE institutional & insider holders · EYE KPIs & operating metrics · EYE financials · EYE investor presentations & press releases · EYE SEC filings · EYE peers · Congress trades · Insider trades · Short interest · Stock screener

Data as of 2026-09-02.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.